Picture of Gabather AB logo

GABA — Gabather AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Gabather AB Submits Clinical Trial Application To Further Advance Development Of GT-002

Jan 22 (Reuters) - Gabather AB  GABAT.ST :
    * GABATHER AB SUBMITS A CLINICAL TRIAL APPLICATION TO
FURTHER
ADVANCE THE DEVELOPMENT OF GT-002
    * GABATHER- SUBMITTED APPLICATION TO REGULATORY AUTHORITIES
IN
PORTUGAL FOR DOUBLE-BLIND, PLACEBO CONTROLLED MULTIPLE ASCENDING
DOSES CLINICAL TRIAL

Source text for Eikon:  ID:nWkr5vdRqY 
Further company coverage:  GABAT.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Gabather AB

See all news